September

UNC partners with NIH to explore genomic testing for newborns
Researchers at UNC plan to sequence the entire genome of 400 infants to determine what useful clinical data can be acquired through the tests.
UNC research points to promising treatment for macular degeneration
Experiments show promising results for a drug that could lead to a lasting treatment for millions of Americans with macular degeneration.
Li Qian receives New Scholar in Aging Award from Ellison Medical Foundation
Qian’s lab plans to investigate the fundamental events underlying the progression of various cardiovascular diseases as well as to discover the basic mechanisms of cell reprogramming.
real doctors, real people - Oliver Smithies
Dr. Oliver Smithies won the Nobel Prize for his research in gene modification. What you may not know is that since he was a child, he's been enthralled with flying.
UNC researchers identify a new pathway that triggers septic shock
This research indicates that both exterior and interior sensors work together to detect the same component of bacterial cell membranes, a molecule called lipopolysaccharide or LPS.
New findings from UNC School of Medicine challenge assumptions about origins of life
UNC biochemists resurrect “molecular fossils” to conduct experiments that undercut the predominant scientific theory of how life began on Earth.
UNC partners with FDA, NIH to create Tobacco Centers of Regulatory Science
Research from new programs to inform potential tobacco regulatory activities
UNC Health Care to host live Facebook chat on newborn genome mapping
Dr. Cynthia Powell of N.C. Children's Hospital and Dr. Jonathan Berg of UNC Lineberger Comprehensive Cancer Center will answer your questions in a live Facebook chat at noon (12 p.m.) Eastern time on Thursday, Sept. 26.
The Otago Exercise Program reduces falls among older adults
Two years ago, the Carolina Geriatric Education Center at the UNC School of Medicine began training physical therapists to use the Otago Exercise Program, an evidence-based intervention program proven to reduce falls among older adults. The reactions from physical therapists and patients have been overwhelmingly positive.
Abiraterone acetate delays quality of life decline in men with metastatic prostate cancer
Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.
Physicians experience increased effort, uncertainty in cross-coverage of radiation oncology patients
Radiation oncology physicians who encounter an unfamiliar case when cross-covering for another physician experience higher levels of perceived workload and may also affect performance, according to research conducted at the University of North Carolina.
UNC scientists identify brain circuitry that triggers overeating
The finding shows that certain parts of brain cells could play a critical role in anorexia, bulimia, binge eating disorder, and obesity.
Share This: